genomiQa brings precision whole genome analytics to routine clinical practice – making whole genome sequencing the norm, not the exception.

CapeDx

Helping clinicians select the best treatment

CapeDx is the most comprehensive cancer genomic test in the world. Available now for research, NATA accreditation for Australia expected mid-2020.

GulfDx

Simplifying the diagnostic odyssey

Whole genome analysis and clinical reporting to help patients and their families quickly diagnose potential genetic diseases. Available now for research, NATA accreditation for Australia expected late-2020.

 

 

Making whole genome the norm, not the exception